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Yersinia enterocolitica is an enteric pathogen capable of causing systemic disease in a murine model. We have
identified a novel protein, systemic factor protein A (SfpA), conserved in other pathogenic bacteria that is
involved in systemic disease. Analysis of bacterial colonization revealed that a sfpA strain is defective in
mesenteric lymph node colonization. Bioinformatics and functional studies suggest that SfpA is a porin.
The genus Yersinia includes three pathogenic species, Yer-
sinia enterocolitica, Yersinia pseudotuberculosis, and Yersinia
pestis, which share a common tropism for lymphoid tissue.
Upon ingestion, Y. enterocolitica survives the harsh acidic en-
vironment of the stomach and progresses to the terminal il-
eum. Once there, the bacterium invades the specialized lym-
phoid tissue of the small intestine known as Peyer’s patches
through interactions with intestinal M cells (5, 9, 12). Success-
ful colonization of the Peyer’s patches can subsequently lead to
dissemination to deeper tissues, including the mesenteric
lymph nodes (MLN), spleen, and liver. Progression of infection
to deeper tissues and pathology of these tissues are most com-
monly seen in immunocompromised individuals (3, 19).
Several factors that have been shown to be involved in var-
ious stages of Y. enterocolitica infection have been identified.
During early stages of colonization, the outer membrane pro-
teins Inv and YadA allow bacteria to adhere to, colonize, and
invade the intestinal epithelium (13, 14, 22–24, 35). The Yops
encoded by the virulence plasmid are essential at later stages of
yersiniosis, presumably to counteract the immune response.
Effectors of this system are injected into host cells to prevent
phagocytosis by macrophages and hinder the release of proin-
flammatory cytokines from macrophages and epithelial and
endothelial cells (31).
Previously, an in vivo expression technology screen was con-
ducted to identify genes in Y. enterocolitica that are expressed
during systemic infection (8). One gene identified in this
screen, sif15, is not found in either Y. pseudotuberculosis or Y.
pestis, and a strain carrying a mutation in sif15 was attenuated
during intraperitoneal competitive infections with wild-type Y.
enterocolitica. Furthermore, in vitro analysis demonstrated that
sif-15 transcription is significantly increased at 37°C (8). Based
on analysis of the sequence around sif15 (YE3039), it does not
appear to be part of an operon (http://www.sanger.ac.uk
/Projects/Y_enterocolitica/). Subsequently, we renamed sif-15
with the designation sfpA (systemic factor protein A) in
order to avoid confusion with Salmonella induced filaments
(Sifs). In this study, we show that SfpA is located in the
membrane and is necessary for sustained colonization of
mesenteric lymph nodes. Furthermore, in vitro data suggest
that SfpA forms a pore in the outer membrane when ex-
pressed in Escherichia coli.
Requirement for SfpA in mesenteric lymph nodes. To fur-
ther define the role of sfpA in virulence, an in-frame deletion
of sfpA was made in Y. enterocolitica strain JB580v (16). Flank-
ing 500-bp regions of sfpA were cloned into the suicide plasmid
pSR47S and subsequently used to exchange the sfpA gene with
a kanamycin cassette by allelic exchange, as described previ-
ously (21). The absence of sfpA was confirmed by Southern
blotting and PCR (data not shown), and the sfpA mutant was
called strain YVM1051. Complementation of the sfpA muta-
tion was carried out as follows. To construct the complement-
ing sfpA strain, the pSR47S plasmid was engineered with re-
gions carrying the intragenic sequence found between the putA
gene (YE1933) and a phage tail gene (YE1931) flanking a
multiple cloning site (pPutA). sfpA was cloned into pPutA at
the multiple cloning site, and sfpA was recombined by allelic
exchange into the sfpA mutant strain (YVM1051) at the site
between YE1933 and YE1931. The construct was confirmed by
Southern blotting and PCR (data not shown). The comple-
menting strain was called YVM1220.
To assess the effect of the sfpA mutation on virulence,
C57BL/6j mice were orally infected with approximately 1 108
sfpA bacteria from an overnight culture grown in Luria-
Bertani broth at 26°C and compared to mice receiving an
analogous inoculation with wild-type Y. enterocolitica (JB580v)
(16). Infections were done as previously described (4, 11).
Subsequently, Peyer’s patches, MLN, and spleens were har-
vested at 1, 3, and 7 days postinfection, and the number of
CFU in each tissue was determined. Bacterial colonization at
24 h postinfection was similar in all three tissues between
wild-type-infected mice and sfpA mutant-infected mice (data
not shown). Bacterial loads in the Peyer’s patches and spleens
were equivalent to those in wild-type-infected tissues at both 3
days and 7 days postinfection (Fig. 1A). However, by day 3
postinfection, a significantly smaller number of bacteria were
recovered from the MLN of mice infected with the sfpA
strain (Fig. 1A). By day 7 postinfection, the number of CFU in
the MLN of sfpA strain-infected mice remained significantly
lower (P  0.0079) than that in wild-type-infected tissues, with
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Washington University School of Medicine, 660 S.
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FIG. 1. Bacterial colonization of the mouse by the sfpA mutant. (A) C57BL/6j mice were orally infected with 108 CFU wild-type Y. enterocolitica
(JB580v) (■) or the sfpA mutant (YVM1051) (). Mice were sacrificed and organs harvested on day 3 and day 7. The bacterial load for each organ
was determined by counting the number of viable bacteria after plating serial dilutions. Results are expressed as CFU per gram of tissue. Each
symbol represents an individual mouse, and symbols on the x axis were below the limits of detection (limits of detection were as follows: for Peyer’s
patches, 240; for MLN, 100; and for spleens, 65). The Mann-Whitney test was used to calculate the P value. (B) C57BL/6j mice were infected
intraperitoneally with 104 CFU of wild-type Y. enterocolitica (JB580v) (■) or the sfpA mutant (YVM1051) (). The Mann-Whitney test was used
to calculate the P value. Bacterial loads for mesenteric lymph nodes were determined as described above. (C) C57BL/6j mice were orally infected
with 108 CFU wild-type Y. enterocolitica (JB580v) (■), the sfpA mutant (YVM1051) (), or the complemented sfpA mutant strain (YVM1220) (Œ).
Every “X” on the x axis represents one dead mouse; symbols on the x axis indicate that the CFU were below the limits of detection. P, Peyer’s patch;
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10 of the sfpA strain-infected mice having no detectable CFU,
in contrast to only 1 wild-type-infected mouse with no detect-
able CFU (limits of detection were as follows: for Peyer’s
patches, 240 CFU; for MLN, 100 CFU; and for spleens, 65
CFU). These results suggest that SfpA is involved in the es-
tablishment, survival, and/or proliferation of Y. enterocolitica in
the MLN.
The altered progression of infection to the MLN during oral
infection with the sfpA mutant suggested that this mutant was
either defective in dissemination from the Peyer’s patches to
the MLN or attenuated in its ability to survive in the MLN. To
clarify the virulence defect of the sfpA mutant, we deter-
mined the ability of the mutant to survive in the MLN inde-
pendent of dissemination from the Peyer’s patches by inocu-
lating mice via intraperitoneal injection, thus bypassing the
Peyer’s patches altogether. C57BL6/j mice were injected with
104 CFU of wild-type or sfpA bacteria that were grown over-
night at 26°C. At 24 hours postinfection, the MLN of all the
mice infected with either strain had equivalent levels of colo-
nization (data not shown). At 3 days postinfection, the MLN of
all the mice infected with either strain had detectable numbers
of bacteria; however, approximately 100-fold fewer bacteria
were recovered from tissues of the sfpA strain-infected ani-
mals (Fig. 1B). By 7 days postinoculation, bacteria were recov-
ered from only 30% of the mice infected with the sfpA mu-
tant, in contrast to 80% of the wild-type-infected mice. The
complementing strain, YVM1220, completely restored viru-
lence and was able to colonize the MLN to wild-type levels
(Fig. 1C). These results indicate that while the sfpA mutant
could establish infection in the MLN, it was attenuated in its
ability to survive in the MLN and was cleared from this tissue
at a much higher rate than that for wild-type bacteria. How-
ever, these results do not rule out an additional defect in
dissemination by the mutant that would result in a smaller
number of bacteria migrating from the Peyer’s patches to the
MLN after oral infection.
In vitro expression of SfpA. SfpA was identified because it
was expressed in the host but not in vitro at 26°C. Furthermore,
Gort and Miller (8) demonstrated that the transcription of
sfpA increases in vitro if bacteria are grown at 37°C. To deter-
mine the effect of transcriptional regulation on the overall
SfpA protein levels in the cell, we generated a SfpHA epitope-
tagged gene fusion and introduced this into the chromosome
of Y. enterocolitica by homologous recombination. Primers
flanking the sfpA gene and primers to amplify two hemagglu-
tinin (HA) tags were used to clone a copy of sfpA with two
C-terminal HA tags into the suicide plasmid pSR47S (21). By
homologous recombination, the native sfpA gene was replaced
with sfpAHA to generate strain YVM1219; substitution of sfpA
with the fusion construct, sfpAHA, was confirmed by Southern
blotting and PCR (data not shown). To examine the expression
of SfpAHA, broth cultures were grown at 26°C and 37°C, and
samples were taken periodically. Total protein from each time
point was separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, transferred to a nitrocellulose membrane
(Schleicher and Schuell), and probed with anti-HA antibody
(Sigma, St. Louis, MO) as described previously (26). The pre-
dicted molecular mass of SfpAHA with its signal sequence is 37
kDa, and that without the signal sequence is 35 kDa. As shown
by transcriptional analysis, SfpAHA expression was absent at
26°C. At 37°C, SfpAHA levels peaked during early log phase
(optical density at 600 nm [OD600]  0.5) and appeared to be
degraded rapidly over time (Fig. 2). To determine the cellular
localization of SfpA, YVM1219 was grown at 37°C overnight
and then subcultured the next day for 2 hours. The cellular
compartments were fractionated, and protein samples from
whole-cell, cytoplasmic, periplasmic, and total membrane frac-
FIG. 2. Levels of SfpAHA in Y. enterocolitica during in vitro growth.
Cultures of Y. enterocolitica sfpAHA (YVM1219) were grown in Luria-
Bertani broth at 26°C or 37°C, samples were collected at various time
points, and aliquots with equivalent OD600 values were loaded into the
lanes. Monoclonal anti-HA antibodies (Sigma, St. Louis, MO) were
used in immunoblot analysis to determine the levels of SfpA.
FIG. 3. Localization and heat modifiability of SfpAHA in Y. entero-
colitica. (A) Y. enterocolitica sfpAHA cultures (YVM1219) were grown
in Luria-Bertani broth at 37°C to an OD600 of 0.5 and fractionated as
described previously (17). Monoclonal anti-HA antibodies were used
in immunoblot analysis. (B) Y. enterocolitica sfpAHA cultures (YVM1219)
were grown as described above. Whole-cell lysates were boiled for 10 min
in -mercaptoethanol (BME) or Laemmli buffer (no BME) to rule out
any effects of the BME. All samples were run in sodium dodecyl sulfate-
polyacrylamide gels and subjected to immunoblot analysis with monoclo-
nal anti-HA antibodies. The 35-kDa molecular mass marker is labeled.
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tions were analyzed by Western blotting (17). To ensure that
proteins did not cross-contaminate fractions, Western blot
analysis was performed using antibodies for known Y. entero-
colitica cytoplasmic (RovA), periplasmic (-lactamase), and
membrane (Inv) proteins (data not shown). SfpAHA was only
present in the whole-cell and membrane fractions (Fig. 3A)
(17). Since the cellular fractionation results suggest that SfpA
is a membrane protein, we wanted to determine if SfpA be-
haves similarly to other gram-negative outer membrane pro-
teins. One hallmark of outer membrane proteins is that they
are heat modifiable, referring to the differences in banding
positions and numbers of bands for boiled versus unboiled
samples (10, 34). Heat changes the conformation of numerous -
pleated sheets, resulting in altered electrophoretic mobility
(15). SfpAHA in Y. enterocolitica showed different mobilities in
boiled and unboiled samples, further suggesting that SfpA is an
outer membrane protein (Fig. 3B).
SfpA appears to be a porin. A protein structure prediction
program (http://bmerc-www.bu.edu/index.html) was used to
further investigate SfpA (29, 33). In silico analysis of the struc-
ture of SfpA predicts the presence of 16 -pleated sheets in the
protein, suggesting the possibility that SfpA is a porin.
-Pleated sheets form -barrels, which are the main structural
components of outer membrane proteins, and porins often
consist of -barrels composed of 16 -pleated sheets (27). In
order to test the prediction that SfpA is a porin, sfpA was
expressed in E. coli MCR106 and tested for growth on minimal
medium in the presence of differently sized sugars (18). E. coli
MCR106 has an internal deletion in the lamB gene, which
encodes an outer membrane maltoporin that allows sugars to
enter the bacterial cell, and therefore it cannot grow on malt-
ose sugars larger than maltotriose unless an alternate porin is
expressed (7, 18, 32). The lamB E. coli strain (MC4100) has
previously been shown to grow on all sizes of maltosaccharides,
from glucose to heptaose (18). Growth of the lamB MCR106
strain expressing SfpA on sugars larger than maltotriose would
suggest that SfpA can function as a porin by allowing larger
sugar nutrients to enter the cell. sfpA was cloned into pTrc99A
to generate pSM1, allowing expression of sfpA from the trc
promoter by induction with isopropyl--D-thiogalactopyrano-
side (IPTG) (1).
The MCR106 and MC4100 strains carrying either pSM1 or
pTrc99A were grown overnight in Luria-Bertani broth, pel-
leted, washed with M63 salts, and plated on minimal medium
containing M63 salts, 10 M IPTG, and 0.2% (wt/vol) of the
indicated sugars (maltosaccharides of increasing size). No
growth inhibition was observed in MC4100 expressing SfpA
(Fig. 4, row C). MCR106 expressing SfpA grew robustly on
sugars up to maltopentaose, but it had only light growth on
maltohexaose and maltoheptaose (Fig. 4, row D). In contrast,
MCR106 carrying the cloning vector pTRC99A grew robustly
on sugars that did not require a dedicated porin such as LamB
for uptake but had light growth on plates with sugars larger
than maltotriose (Fig. 4, row B) (32). These results suggest that
SfpA is able to function as a porin, as evidenced by its increas-
ing the permeability of MCR106 to different carbohydrates.
Conclusions. While the virulence plasmid of Y. enterocolitica
is necessary for virulence, it is not sufficient, suggesting that
there are important virulence factors encoded in the chromo-
some. sfpA is a novel virulence gene carried on the chromo-
FIG. 4. Sugar diffusion through the SfpA porin. sfpA (pSM1) was expressed in the E. coli MCR106 lamB mutant or in lamB E. coli strain
MC4100 and tested for growth on minimal medium in the presence of differently sized sugars. Overnight cultures grown in Luria-Bertani broth
were pelleted, washed with M63 salts, and plated on minimal medium containing M63 salts, 10 M IPTG, and 0.2% (wt/vol) of the indicated sugars.
Growth was assessed after 24 to 48 h at 37°C.
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some that is involved in the colonization of MLN during acute
Y. enterocolitica infection. SfpA has amino acid sequence sim-
ilarity to hypothetical outer membrane proteins in three en-
teric pathogens, namely, Salmonella enterica serovar Typhi,
Escherichia coli O157:H7, and Helicobacter pylori (6, 25, 30).
Interestingly, there are no sfpA homologous in Yersinia pestis
or Yersinia pseudotuberculosis. While its exact mechanism in
virulence is unclear, there are several possible functions for
SfpA. Its activity as a porin within the nutrient-limited envi-
ronment of the host may promote the exchange of nutrients
and solutes. Alternatively, SfpA may have functions similar to
those of the Neisseria gonorrhoeae and Neisseria meningitidis
porins PorB1A and PorB1B, which induce apoptosis in host
cells, act as adjuvants to activate the immune system, and aid in
the invasion of epithelial cells (2, 20, 28). Preliminary data
suggest that when it is expressed in E. coli, SfpA does not act
as an adhesin for Chinese hamster ovary cells or confer serum
resistance (data not shown). Further studies will focus on de-
termining the mechanism by which SfpA affects the survival of
bacteria during systemic infection.
Nucleotide sequence accession number. The nucleotide se-
quence for sfpA has been deposited in GenBank under acces-
sion no. DQ470669.
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